<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="143069">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02097784</url>
  </required_header>
  <id_info>
    <org_study_id>2013.831</org_study_id>
    <nct_id>NCT02097784</nct_id>
  </id_info>
  <brief_title>Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney Injury</brief_title>
  <official_title>Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective study focuses on the interest of the echocardiography for cirrhotic
      patients, who present acute kidney injury corresponding to the criteria of hepatorenal
      syndrome. This echocardiography will be done before the volemic expansion and the final
      diagnostic of hepatorenal syndrome or prerenal azotemia. The primary endpoint is to describe
      the hemodynamic characteristics of this population at the time of acute kidney injury and
      their association with diagnostic of hepatorenal syndrome or prerenal azotemia. Patients
      with elevated filling pressure, predicting poor outcome of volemic expansion will be
      excluded of the study after the echocardiography and will not undergo volemic expansion but
      appropriate management.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Hemodynamic features assessed by echocardiography before the volemic expansion of cirrhotic patients with acute renal injury corresponding to the criteria of hepatorenal syndrome.</measure>
    <time_frame>At Day0 : at the time of diagnostic of acute kidney injury, before volemic expansion.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Systolic and diastolic function assessment, filling pressures, pulmonary arterial hypertension</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerance of volemic expansion, as recommended by international guidelines</measure>
    <time_frame>After 48 hours of volemic expansion</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Clinical tolerance of volemic expansion, acute pulmonary oedema</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response to vasoconstrictor treatment of hepatorenal syndrome, in case of diagnostic of hepatorenal syndrome</measure>
    <time_frame>1 month after inclusion</time_frame>
    <safety_issue>No</safety_issue>
    <description>Renal function recovery, renal replacement therapy, liver transplantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>1 month after inclusion</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Hepatorenal Syndrome</condition>
  <condition>Acute Kidney Injury</condition>
  <condition>Diastolic Function</condition>
  <arm_group>
    <arm_group_label>cirrhosis with portal hypertension,ascite and acute kidney</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <arm_group_label>cirrhosis with portal hypertension,ascite and acute kidney</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients &gt; 18 years

          -  written consent  for the participation of the study

          -  cirrhosis with portal hypertension and ascite

          -  acute kidney injury according to AKIN criteria (rapid increase of creatinine (48
             hours) &gt; 26.4 µmol or &gt; 50% comparing with baseline). Baseline creatinine is the last
             value of creatinine before admission or creatinine at the admission if stable during
             5 days.

          -  absence of argument for acute tubular necrosis or other organic acute renal injury

          -  absence of argument for shock

        Exclusion Criteria:

          -  pregnant women

          -  volemic expansion before echocardiography

          -  portal thrombosis

          -  presence of TIPSS

          -  history of cardiac or renal pathology

          -  atrial fibrillation

          -  cardiac valvulopathy

          -  technical limitation due to echogenicity
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fanny LEBOSSE, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Hôpital de la Croix-Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanny LEBOSSE, Dr</last_name>
      <email>fanny.lebosse@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Marjolaine Beaudoin</last_name>
      <phone>4 26 73 27 02</phone>
      <phone_ext>+33</phone_ext>
      <email>marjolaine.beaudoin@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Fanny LEBOSSE, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 24, 2014</lastchanged_date>
  <firstreceived_date>March 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cirrhosis</keyword>
  <keyword>hepatorenal syndrome</keyword>
  <keyword>acute kidney injury</keyword>
  <keyword>diastolic function</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hepatorenal Syndrome</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
